In addition, QYHJ showed an obvious effect against the gemcitabine (GEM) resistant pancreatic cancer, which probable by inhibiting cell migration, increasing the mRNA expression of lncRNA AB209630, and decreasing the mRNA levels of EphB2, miR-373, and NANOG (Chen et al., 2019). The gene discussed is EPHB2; the disease is familial pancreatic carcinoma.